Xi‐Yang Cui

470 total citations · 2 hit papers
8 papers, 274 citations indexed

About

Xi‐Yang Cui is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry. According to data from OpenAlex, Xi‐Yang Cui has authored 8 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Xi‐Yang Cui's work include Radiopharmaceutical Chemistry and Applications (5 papers), Peptidase Inhibition and Analysis (4 papers) and Click Chemistry and Applications (2 papers). Xi‐Yang Cui is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Peptidase Inhibition and Analysis (4 papers) and Click Chemistry and Applications (2 papers). Xi‐Yang Cui collaborates with scholars based in China, United States and India. Xi‐Yang Cui's co-authors include Zhibo Liu, Yu Liu, Junyi Chen, Mengxin Xu, Zhu Li, Lihui Lu, Shengqing Lv, Qi Li, Yan Ma and Minmin Luo and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Xi‐Yang Cui

8 papers receiving 269 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals

2023 118 citations Bohan Li, Qi Li et al. Cell profile →
Covalent targeted radioligands potentiate radionuclide therapy

2024 89 citations Xi‐Yang Cui, Zhu Li et al. Nature profile →

Peers

Countries citing papers authored by Xi‐Yang Cui

Since Specialization

Citations

This map shows the geographic impact of Xi‐Yang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi‐Yang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi‐Yang Cui more than expected).

Fields of papers citing papers by Xi‐Yang Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi‐Yang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi‐Yang Cui. The network helps show where Xi‐Yang Cui may publish in the future.

Co-authorship network of co-authors of Xi‐Yang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xi‐Yang Cui. A scholar is included among the top collaborators of Xi‐Yang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi‐Yang Cui. Xi‐Yang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Ribosomal Incorporation of Fluorosulfonyloxy-l-Phenylalanine into Macrocyclic Peptides for De Novo Target-Specific Covalent Binders 2025 ·Journal of the American Chemical Society ·(unknown), Pei Liu, Xi‐Yang Cui, Junjie Wu, Wenfeng Cai, Jie Cheng, (unknown), Xiao‐Wei Fan, Youming Zhang, Zhibo Liu, Yizhen Yin	1
2	Design, Structure Optimization, and Preclinical Evaluation of ¹⁸⁸Re-Labeled FAPI for Targeted Radionuclide Therapy 2025 ·Journal of Medicinal Chemistry ·Mengxin Xu, (unknown), Jie Cai, Junyi Chen, (unknown), (unknown), Yü Liu, Xi‐Yang Cui, Jin Du, Zhu Li, Zhibo Liu	1
3	Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy 2024 ·Science Bulletin ·(unknown), Mengxin Xu, (unknown), (unknown), (unknown), Zexuan Ding, Junyi Chen, Xi‐Yang Cui, Zhibo Liu	7
4	Covalent targeted radioligands potentiate radionuclide therapy breakdown → 2024 ·Nature ·Xi‐Yang Cui, Zhu Li, Ziren Kong, Yu Liu, Hao Meng, (unknown), (unknown), Junyi Chen, Mengxin Xu, Yiyan Li, Jingyue Gao, Wenjia Zhu, Zhixin Hao, Li Huo, Shaoyan Liu, Zhi Yang, (unknown)	89
5	Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals breakdown → 2023 ·Cell ·(unknown), (unknown), (unknown), (unknown), Bohan Li, (unknown), Qi Li, Yan Ma, Lihui Lu, Xi‐Yang Cui, Zhibo Liu, Shengqing Lv, Minmin Luo, Qinghua Liu, Yulong Li, Eric Erquan Zhang	118
6	Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Yu Liu, Haocheng Tang, (unknown), Mengxin Xu, Junyi Chen, Xi‐Yang Cui, Yuxiang Han, Zhu Li, Zhibo Liu	21
7	Photocatalytic direct borylation of carboxylic acids 2022 ·Nature Communications ·Qiang Wei, (unknown), (unknown), Xiaolei Chen, (unknown), Xi‐Yang Cui, Wangsuo Wu, Shuming Bai, Zhibo Liu	29
8	China’s radiopharmaceuticals on expressway: 2014–2021 2022 ·Radiochimica Acta ·Xi‐Yang Cui, Yu Liu, (unknown), Zihao Wen, Yichen Li, Haocheng Tang, Juan Diwu, Yuchuan Yang, Mengchao Cui, Zhibo Liu	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact